3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDIV
1
Study Type
Interventional
27
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Melanoma
12
Carcinoma, Non-Small-Cell Lung
8
Neoplasms
4
Lung Neoplasms
4
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Recurrent Squamous Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Motor Activity
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
17
Pancreaticoduodenectomy
15
Surveys and Questionnaires
11
Endoscopic Ultrasound-Guided Fine Needle Aspiration
10
Observation
9
Biopsy
8
Specimen Handling
6
Pancreatectomy
6
Gemcitabine
6
Endosonography
6
Data Collection
6
Surgical Procedures, Operative
5
Magnetic Resonance Spectroscopy
5
Electroporation
5
Biopsy, Fine-Needle
5
Neoadjuvant Therapy
4
Magnetic Resonance Imaging
4
Liquid Biopsy
4
Interviews as Topic
4
Immunologic Techniques
4
Immunohistochemistry
4
Drug Therapy
4
folfirinox
3
Fluorouracil
3
Cholangiopancreatography, Endoscopic Retrograde
3
Albumin-Bound Paclitaxel
3
irinotecan sucrosofate
2
Taxes
2
Sulfonylurea Compounds
2
Secretin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Pancreatic Neoplasms
×
Ipilimumab
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled